Optimizing Care With a Standardized Management Protocol for Patients With Infantile Spasms

Area of Science:

• Pediatric Neurology
• Quality Improvement in Healthcare
• Clinical Protocol Development

Background:

• Infantile spasms (IS) are a severe epilepsy syndrome in infants.
• Optimal initial treatment for IS is crucial for long-term outcomes.
• Variability in IS management protocols can impact treatment efficacy.

Purpose of the Study:

• To implement a standardized management protocol for infantile spasms.
• To increase the proportion of patients receiving guideline-recommended first-line therapy (adrenocorticotropic hormone, corticosteroids, vigabatrin) for IS.
• To evaluate the impact of protocol standardization on IS remission rates.

Main Methods:

• A quality improvement initiative was undertaken to develop and implement a standardized IS management protocol.
• The protocol was based on current best available data and expert consensus.
• Remission rates at 3 months post-diagnosis were compared between pre-standardization and post-standardization patient cohorts.

Main Results:

• The percentage of patients receiving first-line therapy increased from 57% in the pre-standardization cohort to 100% in the post-standardization cohort (P < .001).
• Infantile spasms remission rates at 3 months significantly improved post-standardization (78.8% vs 30.6%, P < .001).
• Protocol standardization was directly associated with improved clinical outcomes.

Conclusions:

• Standardized management protocols for infantile spasms can effectively ensure adherence to first-line therapies.
• Implementation of a standardized protocol significantly enhances infantile spasms remission rates.
• Quality improvement initiatives focusing on protocol standardization are vital for optimizing care in pediatric epilepsy.